Skip to main content
OpenTrials
Completed

NCT Number: NCT07468253

Risk Factors for Inter-eye Asymmetry in Keratoconus Severity

Observational study comparing patients with inter-eye asymmetric keratoconus with patients with inter-eye symmetric keratoconus.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHR Metz-Thionville Hopital de Mercy

Metz, 57085, France

About this study

Detailed description: Keratoconus is a condition resulting in corneal thinning and visual impairment due to irregular astigmatism. Most cases are bilateral, although the severity is often asymmetric between both eyes. The aim of our study is to examine risk factors for inter-eye asymmetry in terms of severity in patients with a confirmed diagnosis of keratoconus. Patients were reviewed for keratoconus staging for each eye according to the Amsler-Krumeich classification to define asymmetry and separated in groups according to the laterality of the worst eye and in a group where both eyes were symmetric in terms of asymmetry. A multivariate logistic regression was performed on various risk factors to explore keratoconus inter-eye asymmetry.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients presenting to the attending ophthalmologist during the study period with previously diagnosed unilateral or bilateral keratoconus
  • Patients newly diagnosed with unilateral or bilateral keratoconus during the study period.

Exclusion criteria

  • Previous corneal surgery
  • Previous corneal crosslinking
  • Previous keratoplasty
  • Previous placement of intrastromal corneal rings

Treatment and study plan

Questionnaire

Behavioral

Questionnaire about eye rubbing habits

Primary outcomes

  1. Risk factors for inter-eye keratoconus asymmetry in terms of severity

    Time frame: Day 1

    Logistic regression

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Régional Metz-Thionville

Other

Registry information

Acronym: ASYMECONE

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Mar 12, 2026
Registry last updated
Mar 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.